Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women

J Clin Oncol. 2008 Feb 10;26(5):745-52. doi: 10.1200/JCO.2007.14.3016.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors / therapeutic use
  • Bone Density Conservation Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Female
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Middle Aged
  • Osteoporosis / etiology
  • Osteoporosis / prevention & control
  • Ovary / drug effects
  • Premenopause
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Bone Density Conservation Agents
  • Tamoxifen
  • Gonadotropin-Releasing Hormone